HIGHLIGHTS
- who: Nicolas Aubert and colleagues from the Centre d'Immunologie et Maladies Infectieuses-Paris, CIMI-PARIS, Sorbonne Université, INSERM, CNRS have published the research: Blockade of HVEM for Prostate Cancer Immunotherapy in Humanized Mice, in the Journal: Cancers 2021, 13, 3009(NES = -1.86, p-value = 0.001, q-value = 0.15 (FDR), p-value = 0.25 (FWER)) in genes downmodulated of /2021/
- what: The authors investigated the therapeutic potential of a monoclonal antibody targeting human HVEM in humanized mice and the underlying cellular and molecular mechanisms associated with therapeutic efficacy. The authors focused this . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.